Quarterly report pursuant to Section 13 or 15(d)

Statements of Stockholders' Equity (Unaudited)

v3.24.1.1.u2
Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Class A Preferred Stock
Preferred Stock
Class A Common Shares
Common Shares
Common Shares
Common Shares
Common Stock Issuable
Additional Paid-in Capital
Accumulated Deficit
Total
Balances at Dec. 31, 2022     $ 11 $ 1,109 $ 374,522 $ (329,369) $ 46,273
Balances (in shares) at Dec. 31, 2022 250,000 845,385 7,100,111        
Issuance of common shares - Founders Agreement       (1,109) 1,109    
Issuance of common shares - Founders Agreement (in shares)     187,134        
Stock-based compensation expenses         235   235
Stock-based compensation expenses (in shares)     5,905        
Exercise of warrants (in shares)     92        
Reverse Split (15:1) adjustment     $ (10)   10    
Net Income (Loss)           (16,693) (16,693)
Balances at Mar. 31, 2023     $ 1   375,876 (346,062) 29,815
Balances (in shares) at Mar. 31, 2023 250,000 845,385 7,293,242        
Balances at Dec. 31, 2023     $ 1 591 380,502 (380,971) 123
Balances (in shares) at Dec. 31, 2023 250,000 845,385 8,374,869        
Issuance of common shares - Founders Agreement       (477) 477    
Issuance of common shares - Founders Agreement (in shares)     353,086        
Issuance of common shares, equity fee on At-the-Market Offering       $ (114) 114    
Issuance of common shares, equity fee on At-the-Market Offering (in shares)     66,003        
Issuance of common shares under ESPP         48   $ 48
Issuance of common shares under ESPP (in shares)     41,774       128,352
Stock-based compensation expenses         76   $ 76
Stock-based compensation expenses (in shares)     5,573        
Exercise of warrants         1   1
Exercise of warrants (in shares)     704,236        
Net Income (Loss)           (5,191) (5,191)
Balances at Mar. 31, 2024     $ 1   $ 381,218 $ (386,162) $ (4,943)
Balances (in shares) at Mar. 31, 2024 250,000 845,385 9,545,541